The Food and Drug Administration aims to ensure hackers can’t remotely access or control medical devices, and it’s asking the private sector to do more to protect those devices.
Earlier this month, FDA issued draft guidance directing manufacturers to conduct “postmarket” evaluation of their devices, ensuring device security vulnerabilities won’t affect clinical performance.